„The Report Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H1 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz“
Global Markets Directs, Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H1 2016, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects.
View Report At http://www.marketresearchreports.biz/analysis/685462
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Download Sample copy of this Report at : http://www.marketresearchreports.biz/sample/sample/685462
Scope
– The report provides a snapshot of the global therapeutic landscape of Acute Renal Failure (ARF) (Acute Kidney Injury)
– The report reviews pipeline therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury) by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Acute Renal Failure (ARF) (Acute Kidney Injury) therapeutics and enlists all their major and minor projects
– The report assesses Acute Renal Failure (ARF) (Acute Kidney Injury) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury)
Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury)
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Acute Renal Failure (ARF) (Acute Kidney Injury) Overview 10
Therapeutics Development 11
Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) – Overview 11
Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) – Comparative Analysis 12
Acute Renal Failure (ARF) (Acute Kidney Injury) – Therapeutics under Development by Companies 13
Acute Renal Failure (ARF) (Acute Kidney Injury) – Therapeutics under Investigation by Universities/Institutes 15
Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Products Glance 16
Clinical Stage Products 16
Early Stage Products 17
Acute Renal Failure (ARF) (Acute Kidney Injury) – Products under Development by Companies 18
Acute Renal Failure (ARF) (Acute Kidney Injury) – Products under Investigation by Universities/Institutes 20
Acute Renal Failure (ARF) (Acute Kidney Injury) – Companies Involved in Therapeutics Development 21
A1M Pharma AB 21
Adrenomed AG 22
Am-Pharma B.V. 23
Angion Biomedica Corp. 24
Atox Bio Inc. 25
Cellmid Limited 26
Complexa, Inc. 27
DiaMedica Inc. 28
Digna Biotech, S.L. 29
DURECT Corporation 30
F. Hoffmann-La Roche Ltd. 31
G1 Therapeutics, Inc. 32
Ischemix, Inc. 33
Kringle Pharma, Inc. 34
NephroGenex, Inc. 35
NeuroVive Pharmaceutical AB 36
Noorik Biopharmaceuticals AG 37
Noxxon Pharma AG 38
Nyken B.V. 39
Orion Oyj 40
ProMetic Life Sciences Inc. 41
Quark Pharmaceuticals, Inc. 42
SBI Pharmaceuticals Co., Ltd. 43
Spherium Biomed S.L. 44
STATegics, Inc. 45
Thrasos Therapeutics Inc. 46
Torrent Pharmaceuticals Limited 47
Acute Renal Failure (ARF) (Acute Kidney Injury) – Therapeutics Assessment 48
Assessment by Monotherapy Products 48
Assessment by Combination Products 49
Assessment by Target 50
Assessment by Mechanism of Action 52
Assessment by Route of Administration 54
Assessment by Molecule Type 56
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074